selection and use of the non-anti-tnf biological therapies? who? when? how?
Published 9 years ago • 846 plays • Length 20:54Download video MP4
Download video MP3
Similar videos
-
18:23
selection and use of the new and coming therapies for ibd? who? when? how?
-
23:55
new biologic therapies that target the il-12/23 pathway
-
15:09
novel targets and therapeutic perspectives in ibd: beyond anti-tnf
-
16:10
when should we stop anti-tnf therapy and how do we then treat the patient?
-
18:23
who should receive early anti-tnf therapy: with what benefits and risks?
-
21:59
the treatment of moderate to severe ibd with anti-tnf biologics and immunomodulators
-
11:37
debate: is combination therapy necessary if you use anti-tnf? - yes
-
21:14
when and how to use immunomodulators and biologics in ibd
-
7:06
tnf inhibitors and autoimmune disease
-
23:36
revisiting anti-tnf 20 years later
-
10:50
treat-to-target in ibd: decreasing inflammation & achieving mucosal healing
-
17:29
optimizing biological therapies in the modern era
-
14:56
debate: is therapeutic drug monitoring necessary with anti-tnf therapy? - yes
-
17:48
case-based discussion: individualizing ibd treatment goals and therapeutic selection
-
14:13
what do we do when the patient loses their response to an anti-tnf?
-
26:15
therapeutic drug monitoring in ibd: when, how, and for which drugs?
-
3:35
tnf inhibitors: an overview
-
15:28
jak therapies: mechanism of action, pharmacotherapeutic profiles, and positioning
-
30:34
advances in anti-cytokine therapy for ibd: the role of il-12/23 and il-23 inhibitors
-
12:32
use of anti-tnf therapies for crohn's disease
-
44:08
the evolution of personalized ibd care: navigating mechanisms of biologic therapies
-
15:56
therapeutic approaches to ibd in 2020 and beyond